SCHEMBL23633671

SCHEMBL23633671

c1ccc2cc(-c3nc(-c4ccc5ccccc5c4)nc(-c4cc(-c5ccc6ccccc6c5)c5ccccc5c4)n3)ccc2c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GSTP1 P09211 1/20 0.48
▸ CYP1A2 P05177 5/20 0.44
▸ CYP2C9 P11712 2/20 0.44
▸ CYP2C19 P33261 2/20 0.44
▸ CYP11B1 P15538 2/20 0.44
▸ CYP11B2 P19099 2/20 0.44
▸ CYP3A4 P08684 1/20 0.44
▸ CYP2D6 P10635 1/20 0.44
▸ CYP2B6 P20813 1/20 0.44
▸ GPR84 Q9NQS5 1/20 0.43
▸ DHFR P00374 1/20 0.42
▸ KDM4E B2RXH2 3/20 0.41
▸ ALDH1A1 P00352 3/20 0.41
▸ HPGD P15428 2/20 0.41
▸ NPSR1 Q6W5P4 1/20 0.41
▸ HDAC4 P56524 1/20 0.41
▸ HDAC2 Q92769 1/20 0.41
▸ HDAC8 Q9BY41 1/20 0.41
▸ MEN1 O00255 2/20 0.41
▸ KMT2A Q03164 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23633713 0.92 MEN1 (0.49) GSTP1CYP1A2CYP11B1CYP11B2GPR84
SCHEMBL23633643 0.92 KDM4E (0.49) GSTP1CYP1A2CYP11B1CYP11B2GPR84
SCHEMBL26154646 0.92 MEN1 (0.47) GSTP1CYP1A2CYP2C9CYP2C19CYP11B1
SCHEMBL24377039 0.92 KDM4E (0.45) GSTP1CYP1A2CYP2C9CYP2C19CYP11B1
SCHEMBL27252870 0.90 ALDH1A1 (0.46) GSTP1CYP1A2CYP2C9CYP2C19CYP11B1
SCHEMBL24377064 0.90 KDM4E (0.47) GSTP1CYP1A2CYP11B1CYP11B2GPR84
SCHEMBL23633607 0.89 ALDH1A1 (0.43) GSTP1CYP1A2CYP2C9CYP2C19CYP11B1
SCHEMBL24377059 0.88 KDM4E (0.49) GSTP1CYP1A2CYP11B1CYP11B2GPR84
SCHEMBL24343251 0.87 HCRTR1 (0.40) GSTP1CYP1A2CYP2C9CYP2C19CYP11B1
SCHEMBL21109769 0.87 HCRTR1 (0.40) GSTP1CYP1A2CYP2C9CYP2C19CYP11B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11917914-B1 Compound for organic electronic element, organic electronic element using the same, and an electronic device thereof DUK SAN NEOLUX CO., LTD. (KR) 2024-02-27 — — US disclosed
US-11917914-B1 Compound for organic electronic element, organic electronic element using the same, and an electronic device thereof DUK SAN NEOLUX CO., LTD. (KR) 2024-02-27 — — US disclosed
US-20230225206-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF DUK SAN NEOLUX CO., LTD. (KR) 2023-07-13 — — US disclosed
US-20230225206-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF DUK SAN NEOLUX CO., LTD. (KR) 2023-07-13 — — US disclosed
US-11678577-B2 Organic electronic element comprising compound for organic electronic element and an electronic device thereof DUK SAN NEOLUX CO., LTD. (KR) 2023-06-13 — — US disclosed
US-11678577-B2 Organic electronic element comprising compound for organic electronic element and an electronic device thereof DUK SAN NEOLUX CO., LTD. (KR) 2023-06-13 — — US disclosed
US-20230172055-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF DUK SAN NEOLUX CO., LTD. (KR) 2023-06-01 — — US disclosed
US-20230172055-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF DUK SAN NEOLUX CO., LTD. (KR) 2023-06-01 — — US disclosed
WO-2023096210-A1 COMPOUND FOR ORGANIC ELECTRICAL ELEMENT, ORGANIC ELECTRICAL ELEMENT USING SAME AND ELECTRONIC DEVICE THEREFOR 덕산네오룩스 주식회사 2023-06-01 — — WO disclosed
US-11665958-B1 Compound for organic electronic element, organic electronic element using the same, and an electronic device thereof DUK SAN NEOLUX CO., LTD. (KR) 2023-05-30 — — US disclosed
US-11665958-B1 Compound for organic electronic element, organic electronic element using the same, and an electronic device thereof DUK SAN NEOLUX CO., LTD. (KR) 2023-05-30 — — US disclosed
US-20220131090-A1 ORGANIC ELECTRONIC ELEMENT COMPRISING COMPOUND FOR ORGANIC ELECTRONIC ELEMENT AND AN ELECTRONIC DEVICE THEREOF DUK SAN NEOLUX CO., LTD. (KR) 2022-04-28 — — US disclosed
US-11063226-B1 Organic electronic element comprising compound for organic electronic element and an electronic device thereof DUK SAN NEOLUX CO., LTD. (KR) 2021-07-13 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11678577-B2 Organic electronic element comprising compound for organic electronic element and an electronic device thereof ESR1, EML4, OCIAD2 GSTP1 2208/4885CYP1A2 462/4885CYP2C9 337/4885
US-20230172055-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF OR51E2, NFE2L2, ETV6 GSTP1 2058/4885CYP1A2 2403/4885CYP2C9 942/4885
US-11917914-B1 Compound for organic electronic element, organic electronic element using the same, and an electronic device thereof NFE2L2, ESR1, OR51E2 GSTP1 1825/4885CYP1A2 1608/4885CYP2C9 718/4885
US-20230225206-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF NFE2L2, ESR1, OR51E2 GSTP1 1825/4885CYP1A2 1608/4885CYP2C9 718/4885
US-11665958-B1 Compound for organic electronic element, organic electronic element using the same, and an electronic device thereof OR51E2, NFE2L2, ETV6 GSTP1 2058/4885CYP1A2 2403/4885CYP2C9 942/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback